Cronos Group Inc (TO:CRON) — Market Cap & Net Worth
Market Cap & Net Worth: Cronos Group Inc (CRON)
Cronos Group Inc (TO:CRON) has a market capitalization of $1.09 Billion (CA$1.51 Billion) as of August 5, 2026. Listed on the TO stock exchange, this Canada-based company holds position #8421 globally and #257 in its home market, demonstrating a 1.80% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cronos Group Inc's stock price CA$3.95 by its total outstanding shares 382893267 (382.89 Million). See capital reinvestment ratio of Cronos Group Inc to understand how much of operating cash flow is reinvested back into capital assets.
Cronos Group Inc Market Cap History: 2015 to 2026
Cronos Group Inc's market capitalization history from 2015 to 2026. Data shows growth from $87.25 Million to $1.09 Billion (25.52% CAGR).
Cronos Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cronos Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.81x
Cronos Group Inc's market cap is 6.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
19.50x
Cronos Group Inc's market cap is 19.50 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $87.25 Million | $2.46 Million | $278.73K | 35.50x | 313.02x |
| 2016 | $409.93 Million | $409.79K | -$880.23K | 1000.35x | N/A |
| 2017 | $2.70 Billion | $3.11 Million | -$1.47 Million | 867.28x | N/A |
| 2018 | $3.98 Billion | $13.09 Million | -$23.37 Million | 304.17x | N/A |
| 2019 | $2.76 Billion | $23.16 Million | $1.14 Billion | 119.22x | 2.43x |
| 2020 | $2.45 Billion | $46.57 Million | -$72.90 Million | 52.58x | N/A |
| 2021 | $1.38 Billion | $64.02 Million | -$392.81 Million | 21.54x | N/A |
| 2022 | $952.81 Million | $87.54 Million | -$170.26 Million | 10.88x | N/A |
| 2023 | $767.23 Million | $87.03 Million | -$73.79 Million | 8.82x | N/A |
| 2024 | $800.47 Million | $117.50 Million | $41.04 Million | 6.81x | 19.50x |
Competitor Companies of CRON by Market Capitalization
Companies near Cronos Group Inc in the global market cap rankings as of August 5, 2026.
Key companies related to Cronos Group Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #504 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #543 globally with a market cap of $49.47 Billion USD ( CN¥338.09 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #504 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #543 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.47 Billion | CN¥53.00 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.97 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
Cronos Group Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Cronos Group Inc's market cap moved from $87.25 Million to $ 1.09 Billion, with a yearly change of 25.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.09 Billion | +9.72% |
| 2025 | CA$997.12 Million | +24.57% |
| 2024 | CA$800.47 Million | +4.33% |
| 2023 | CA$767.23 Million | -19.48% |
| 2022 | CA$952.81 Million | -30.92% |
| 2021 | CA$1.38 Billion | -43.67% |
| 2020 | CA$2.45 Billion | -11.33% |
| 2019 | CA$2.76 Billion | -30.67% |
| 2018 | CA$3.98 Billion | +47.64% |
| 2017 | CA$2.70 Billion | +558.11% |
| 2016 | CA$409.93 Million | +369.84% |
| 2015 | CA$87.25 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Cronos Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.09 Billion USD |
| MoneyControl | $1.09 Billion USD |
| MarketWatch | $1.09 Billion USD |
| marketcap.company | $1.09 Billion USD |
| Reuters | $1.09 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.